Poxel S.A. (POXEL.PA)
EUR 0.13
(-0.94%)
EUR 0.13
(-0.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.95 Million EUR | 0.0% |
| 2022 | - EUR | 100.0% |
| 2021 | - EUR | -100.0% |
| 2020 | 1.00 EUR | -100.0% |
| 2019 | 898 Thousand EUR | 89799900.0% |
| 2018 | 1.00 EUR | -100.0% |
| 2017 | 552.28 Thousand EUR | 89411.35% |
| 2016 | 617.00 EUR | 173.01% |
| 2015 | 226.00 EUR | 108.09% |
| 2014 | -2794.00 EUR | 0.0% |
| 2013 | - EUR | 0.0% |
| 2012 | - EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | - EUR | 0.0% |
| 2023 FY | - EUR | 0.0% |
| 2023 Q4 | 2.95 Million EUR | 0.0% |
| 2022 Q2 | 4.5 Million EUR | 0.0% |
| 2022 Q4 | - EUR | 0.0% |
| 2022 FY | - EUR | 100.0% |
| 2021 FY | - EUR | -100.0% |
| 2021 Q4 | - EUR | 0.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2020 Q4 | 1.00 EUR | 0.0% |
| 2020 FY | 1.00 EUR | -100.0% |
| 2020 Q2 | 531 Thousand EUR | 0.0% |
| 2019 Q2 | 1.3 Million EUR | 0.0% |
| 2019 Q4 | 898 Thousand EUR | 0.0% |
| 2019 FY | 898 Thousand EUR | 89799900.0% |
| 2018 Q2 | -11.31 Million EUR | 0.0% |
| 2018 FY | 1.00 EUR | -100.0% |
| 2018 Q4 | 1.00 EUR | 0.0% |
| 2017 Q2 | -1845.00 EUR | 0.0% |
| 2017 FY | 552.28 Thousand EUR | 89411.35% |
| 2017 Q4 | 7.18 Million EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 FY | 617.00 EUR | 173.01% |
| 2016 Q4 | -36.51 Thousand EUR | 0.0% |
| 2015 FY | 226.00 EUR | 108.09% |
| 2015 Q2 | -60 Thousand EUR | 0.0% |
| 2015 Q4 | -11.8 Thousand EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 Q4 | -2794.00 EUR | 0.0% |
| 2014 FY | -2794.00 EUR | 0.0% |
| 2013 Q4 | - EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| 2012 FY | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | -1237.557% |
| ABIVAX Société Anonyme | 1.00 EUR | -295599900.0% |
| Adocia SA | 272 Thousand EUR | -986.765% |
| Aelis Farma SA | 53 Thousand EUR | -5477.358% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | -69.787% |
| genOway Société anonyme | 982.75 Thousand EUR | -200.788% |
| IntegraGen SA | 311.44 Thousand EUR | -849.112% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | -1695.629% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 366.629% |
| Plant Advanced Technologies SA | 1.22 Million EUR | -141.392% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 2580.365% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -3148.352% |
| Valbiotis SA | 1 Million EUR | -194.13% |
| TheraVet SA | 123.34 Thousand EUR | -2296.588% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -295599900.0% |
| argenx SE | 281.12 Million EUR | 98.949% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | -134.603% |
| DBV Technologies S.A. | 1.00 USD | -295599900.0% |
| Galapagos NV | 73.97 Million EUR | 96.004% |
| Genfit S.A. | 4000.00 EUR | -73800.0% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -295599900.0% |
| Innate Pharma S.A. | 1.00 EUR | -295599900.0% |
| Inventiva S.A. | 417 Thousand EUR | -608.873% |
| MaaT Pharma SA | 190 Thousand EUR | -1455.789% |
| MedinCell S.A. | -6.71 Million EUR | 144.027% |
| Nanobiotix S.A. | 200 Thousand EUR | -1378.0% |
| Onward Medical N.V. | 936 Thousand EUR | -215.812% |
| Oryzon Genomics S.A. | 6029.00 EUR | -48929.69% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | -2209.375% |
| Pharming Group N.V. | 51.38 Million EUR | 94.247% |
| GenSight Biologics S.A. | 1.00 EUR | -295599900.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.713% |
| Valneva SE | 44.46 Million EUR | 93.352% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -295599900.0% |